Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Dividends Paid - Common (2020 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Dividends Paid - Common for 8 consecutive years, with $1.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Dividends Paid - Common rose 28.19% to $1.9 million in Q3 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 13.02% increase, with the full-year FY2025 number at $3.9 million, up 30.45% from a year prior.
  • Dividends Paid - Common was $1.9 million for Q3 2025 at Acadia Healthcare Company, up from $1.5 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.9 million in Q3 2025 to a low of $157000.0 in Q3 2022.
  • A 5-year average of $813461.5 and a median of $480000.0 in 2024 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: tumbled 46.42% in 2022, then soared 853.5% in 2023.
  • Acadia Healthcare Company's Dividends Paid - Common stood at $662000.0 in 2021, then plummeted by 76.28% to $157000.0 in 2022, then skyrocketed by 936.31% to $1.6 million in 2023, then decreased by 9.53% to $1.5 million in 2024, then rose by 28.19% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Dividends Paid - Common are $1.9 million (Q3 2025), $1.5 million (Q3 2024), and $480000.0 (Q2 2024).